COYA (STOCKS)
Coya Therapeutics, Inc. Common Stock
$4.930000
-0.030000 (-0.60%)
Prev close: $4.960000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Arun Swaminathan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $105.93M
- Employees
- 8
- P/E (TTM)
- -4.50
- P/B (TTM)
- 3.04
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $3.99M |
| Benefits Costs and Expenses | $23.14M |
| Costs And Expenses | $23.14M |
| Operating Expenses | $24.59M |
| Operating Income/Loss | -$20.60M |
| Income/Loss From Continuing Operations After Tax | -$18.43M |
| Income/Loss From Continuing Operations Before Tax | -$13.47M |
| Net Income/Loss | -$18.43M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$18.43M |
| Net Income/Loss Available To Common Stockholders, Basic | -$18.43M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.11 |
| Diluted Earnings Per Share | -$1.11 |
| Basic Average Shares | 17,098,938 |
| Diluted Average Shares | 17,098,938 |
| Assets | $32.04M |
| Current Assets | $32.02M |
| Noncurrent Assets | $18.07K |
| Fixed Assets | $18.07K |
| Liabilities | $4.76M |
| Current Liabilities | $3.67M |
| Accounts Payable | $1.11M |
| Other Current Liabilities | $2.56M |
| Noncurrent Liabilities | $1.09M |
| Equity | $27.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $27.28M |
| Liabilities And Equity | $32.04M |
| Net Cash Flow From Operating Activities | -$12.14M |
| Net Cash Flow From Operating Activities, Continuing | -$12.14M |
| Net Cash Flow From Investing Activities | -$516.00K |
| Net Cash Flow From Investing Activities, Continuing | -$516.00K |
| Net Cash Flow From Financing Activities | $9.73M |
| Net Cash Flow From Financing Activities, Continuing | $9.73M |
| Net Cash Flow | -$2.93M |
| Net Cash Flow, Continuing | -$2.93M |
| Comprehensive Income/Loss | -$18.43M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$18.43M |
| Other Comprehensive Income/Loss | $0.00 |